| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
YK Banryoku
|
30.636m | 38.65% | — | May 01 2026 |
| 2 |
SMBC Trust Bank (Trust)
|
6.503m | 8.20% | — | Nov 30 2025 |
| 3 |
Baillie Gifford & Co.
|
6.120m | 7.72% | +793.700k | Feb 13 2026 |
| 4 |
Nomura Asset Management Co., Ltd.
|
5.502m | 6.94% | +897.600k | Apr 15 2026 |
| 5 |
Public Foundation Yokeikai
|
3.000m | 3.79% | — | Nov 30 2025 |
|
1
YK Banryoku
|
38.65%
30.636m
|
|
2
SMBC Trust Bank (Trust)
|
8.20%
6.503m
|
|
3
Baillie Gifford & Co.
|
7.72%
6.120m
|
|
4
Nomura Asset Management Co., Ltd.
|
6.94%
5.502m
|
|
5
Public Foundation Yokeikai
|
3.79%
3.000m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 65.31% of Cosmos Pharmaceutical Corp, with YK Banryoku the biggest at 38.65%, followed by SMBC Trust Bank (Trust) (8.20%) and Baillie Gifford & Co. (7.72%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


